At the end of the year, the pharmaceutical companies "rushed their achievements", selling houses and land, and selling trees

[industry trends of pharmaceutical network] by the end of this year, many pharmaceutical companies are making achievements in various ways For example, Haizheng Pharmaceutical Co., Ltd disposed 22 apartments of Jiaojiang Junyue building twice through auction, with a total transaction amount of 8.1708 million yuan; on the evening of December 13, fosci pharmaceutical announced that the company planned to transfer two lands located at No.2 Daijiazhuang, Anning District, Lanzhou and south side of Zhonghai square, Mogao Avenue, Anning District, Lanzhou to fosci group, the controlling shareholder, at a price of 103 million yuan; on December 14, Shuangcheng The pharmaceutical industry announced that it plans to sell the rights related to bevaludine for injection at a price of 50 million yuan This transaction is expected to increase the company's profits by about 37.5 million yuan.. It is not uncommon for pharmaceutical enterprises to dispose of assets by selling houses, selling land, selling product rights and other methods Now some enterprises have even sold trees! On December 14, Sihuan biological disclosed the announcement on the sale of assets by wholly-owned subsidiaries that Guangxi intercontinental, a wholly-owned subsidiary, transferred the contracted forest trees and corresponding forest land use rights in Babu District, Bama County, Beiliu City and other places to 60000 forest farms with the transfer price of about 171 million yuan Data shows that Sihuan biology is a high-tech enterprise engaged in research, pilot test, production and sales of genetically engineered drugs and diagnostic reagents, integrating science, industry and trade Judging from the financial data, the performance of Sihuan biology in recent years seems to be somewhat unsatisfactory From 2015 to 2018, the company realized net profits of - 74.45 million yuan, 4.47 million yuan, 7.29 million yuan and - 29.44 million yuan respectively, basically in the state of big loss and small profit In the first half of 2019, the net loss of Sihuan biology was RMB 09 million, but the third quarter report shows that the net profit of Sihuan biology has been corrected to RMB 09 million Sihuan biology once said in its 2018 annual report that in recent years, the company's pharmaceutical industry operation situation has become increasingly severe The main reason is that the company is seeking industrial transformation in order to constantly optimize its profitability and improve its sustainable development ability It is understood that in 2017, Sihuan biological Co., Ltd held 12% equity in Beijing Sihuan Biological Pharmaceutical Co., Ltd and Guangxi intercontinental 100% equity held by Guangxi sunshine Forestry Development Co., Ltd were exchanged According to the plan, the transaction price of 12% equity replacement of Beijing Sihuan held by Sihuan biology is 61 million 320 thousand yuan, the transaction price of 100% equity replacement of Guangxi intercontinental held by Guangxi sunshine forestry is 59 million yuan, and the price difference of 2 million 320 thousand yuan is paid to the listed company by Guangxi sunshine forestry After the completion of equity replacement, Sihuan biology holds 100% equity of Guangxi intercontinental It can be seen that the transformation direction of the biological industry in the Fourth Ring Road should be ecological agriculture However, it is worth mentioning that the underlying assets of this transaction are exactly the equity exchange of Sihuan biology in 2017 In less than two years, Sihuan biology sold its important assets of transformation, forest assets Why? In response, Sihuan biology said in the announcement that the purpose of the sale of forest assets is to activate the stock assets, improve the efficiency of asset operation, improve the financial situation of the company After the completion of the transaction, it can reduce the proportion of the company's inventory, supplement the company's cash flow, meet the needs of the company's overall development strategy, and have a positive impact on the company's production and operation It is reported that after the completion of this transaction, Sihuan biology will generate about 40 million earnings, and the data is subject to the company's audit report On the same day, Sihuan biology also announced that Chenwei ecological park and Jiangxi sunshine Cultural Tourism Development Co., Ltd signed the landscape greening contract for Huaxia sunshine (De'an) idyllic cultural tourism scenic spot on December 13, 2019 The estimated total price of the project contract is 40.81 million yuan At the same time, the landscape (installation) and supporting facilities of the contract project will be settled by 7% of the overall price It is reported that Chenwei ecological park is another pillar of the transformation of the Fourth Ring biology to agriculture and forestry.